Table 4.
Marker | Size (bp) | Polymorphic sites (S) | Haplotypes | Haplotype diversity (Hd) | Nucleotide diversity (π × 10-3) | Nucleotide poly-morphism (θ × 10-3) | Tajima's D |
---|---|---|---|---|---|---|---|
LK1457 | 526 | 12 | 5 | 0.705 | 8.47 | 4.75 | 2.19978 * |
LK1457 (exons) | 270 | 2 | 3 | 0.634 | 3.02 | 1.54 | 1.59391 |
Cntg10044 | 727 | 29 | 10 | 0.760 | 5.10 | 8.30 | -1.22415 |
Cntg10044 (exons) | 330 | 6 | 8 | 0.758 | 4.55 | 3.78 | 0.4853 |
QGG19E03 (exons) | 673 | 14 | 5 | 0.593 | 7.05 | 4.98 | 1.27593 |
Cntg4252 | 1021 | 16 | 6 | 0.747 | 5.91 | 3.29 | 2.3525 * |
Cntg4252 (exons) | 852 | 7 | 5 | 0.722 | 2.37 | 1.73 | 0.9381 |
Cntg10192 (exons) | 348 | 3 | 3 | 0.644 | 5.33 | 2.39 | 2.78285 ** |
CLSM9959 (exons) | 302 | 4 | 5 | 0.763 | 6.27 | 2.75 | 2.7119 ** |
CLSZ1525 (exons) | 492 | 35 | 5 | 0.783 | 31.22 | 15.23 | 3.3968 *** |
QGC11N03 (exons) | 518 | 28 | 7 | 0.783 | 7.43 | 11.32 | -1.09141 |
Cntg11275 | 840 | 29 | 7 | 0.809 | 8.67 | 4.67 | 2.11930 * |
Cntg11275 (exons) | 384 | 4 | 5 | 0.729 | 2.55 | 1.65 | 1.23874 |
Five of the markers consist of exons only, while the remaining four markers consist of a combination of exons and introns. Analyzed fragments are shorter than amplified markers, because indels, VNTRs, and some poor sequences were deleted prior to data analysis. *, **, and *** indicate the significance of Tajima's D test at p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001 (respectively).